PIK3CA mutation is a favorable prognostic factor in esophageal cancer: Molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue
BMC Cancer Aug 22, 2018
Yokota T, et al. - Researchers assessed gene alteration profiles of cancer-related genes in Japanese esophageal cancer patients by performing next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue. They also correlated those profiles with clinicopathological features, such as smoking status and survival outcomes. Via amplicon-based massively parallel sequencing, they identified frequent gene alterations in TP53 (66.7%), PIK3CA (13.5%), APC (10.3%), ERBB4 (7.9%), and FBXW7 (7.9%). No link was observed between clinicopathological features or prognosis with smoking status. Not only profiles of cancer-related genes were identified by next-generation sequencing in this study, but also PIK3CA mutation was identified as a favorable prognosis biomarker.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries